BioMarin Pharmaceutical Inc. (BMV:BMRN)
Mexico · Delayed Price · Currency is MXN 992.10
0.00 (0.00%)
At close: Sep 30, 2025
BioMarin Pharmaceutical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Cash & Equivalents | 1,214 | 942.84 | 755.13 | 724.53 | 587.28 | 649.16 | Upgrade |
Short-Term Investments | 218.31 | 194.86 | 318.68 | 567.01 | 426.6 | 416.23 | Upgrade |
Cash & Short-Term Investments | 1,432 | 1,138 | 1,074 | 1,292 | 1,014 | 1,065 | Upgrade |
Cash Growth | 16.97% | 5.95% | -16.86% | 27.39% | -4.83% | 41.33% | Upgrade |
Accounts Receivable | 855.86 | 660.54 | 633.7 | 461.32 | 373.4 | 448.35 | Upgrade |
Inventory | 1,340 | 1,233 | 1,107 | 894.08 | 776.67 | 698.55 | Upgrade |
Other Current Assets | 177.18 | 201.53 | 141.39 | 104.52 | 110.44 | 129.93 | Upgrade |
Total Current Assets | 3,805 | 3,232 | 2,956 | 2,751 | 2,274 | 2,342 | Upgrade |
Net Property, Plant & Equipment | 1,030 | 1,043 | 1,066 | 1,073 | 1,035 | 1,032 | Upgrade |
Other Intangible Assets | 239.62 | 255.28 | 294.7 | 338.57 | 388.65 | 417.27 | Upgrade |
Goodwill | 196.2 | 196.2 | 196.2 | 196.2 | 196.2 | 196.2 | Upgrade |
Long-Term Investments | 508.59 | 521.24 | 611.14 | 333.84 | 507.79 | 285.47 | Upgrade |
Other Long-Term Assets | 1,676 | 1,741 | 1,717 | 1,682 | 1,602 | 1,574 | Upgrade |
Total Assets | 7,456 | 6,989 | 6,842 | 6,375 | 6,005 | 5,848 | Upgrade |
Accounts Payable | 684.25 | 606.99 | 683.15 | 572.96 | 498.27 | 492.55 | Upgrade |
Short-Term Debt | - | - | 493.88 | - | - | - | Upgrade |
Other Current Liabilities | - | - | - | 15.93 | 48.23 | - | Upgrade |
Total Current Liabilities | 684.25 | 606.99 | 1,177 | 588.88 | 546.5 | 492.55 | Upgrade |
Long-Term Debt | 596.16 | 595.14 | 593.1 | 1,083 | 1,079 | 1,075 | Upgrade |
Other Long-Term Liabilities | 148.82 | 128.82 | 119.94 | 100.02 | 113.53 | 174.33 | Upgrade |
Total Long-Term Liabilities | 744.98 | 723.96 | 713.03 | 1,183 | 1,193 | 1,249 | Upgrade |
Total Liabilities | 1,429 | 1,331 | 1,890 | 1,772 | 1,739 | 1,742 | Upgrade |
Common Stock | 0.19 | 0.19 | 0.19 | 0.19 | 0.18 | 0.18 | Upgrade |
Treasury Stock | -11.67 | -11.23 | -9.86 | -8.86 | -9.69 | -9.84 | Upgrade |
Additional Paid-in Capital | 5,852 | 5,802 | 5,612 | 5,405 | 5,192 | 4,993 | Upgrade |
Accumulated Other Comprehensive Income | -44.57 | 61.65 | -28.79 | -3.87 | 14.43 | -16.14 | Upgrade |
Retained Earnings | 231.52 | -194.7 | -621.55 | -789.2 | -930.76 | -861.61 | Upgrade |
Shareholders' Equity | 6,027 | 5,658 | 4,952 | 4,603 | 4,266 | 4,106 | Upgrade |
Total Liabilities & Equity | 7,456 | 6,989 | 6,842 | 6,375 | 6,005 | 5,848 | Upgrade |
Total Debt | 596.16 | 595.14 | 1,087 | 1,083 | 1,079 | 1,075 | Upgrade |
Net Cash (Debt) | 835.96 | 542.57 | -13.16 | 208.52 | -65.2 | -9.76 | Upgrade |
Net Cash Growth | 54.07% | - | - | - | - | - | Upgrade |
Net Cash Per Share | 4.25 | 2.76 | -0.07 | 1.10 | -0.36 | -0.05 | Upgrade |
Book Value | 6,027 | 5,658 | 4,952 | 4,603 | 4,266 | 4,106 | Upgrade |
Book Value Per Share | 30.61 | 28.76 | 25.84 | 24.36 | 23.33 | 21.42 | Upgrade |
Tangible Book Value | 5,591 | 5,207 | 4,461 | 4,068 | 3,681 | 3,493 | Upgrade |
Tangible Book Value Per Share | 28.40 | 26.47 | 23.28 | 21.53 | 20.13 | 18.22 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.